← All Sponsors
SPONSOR

Washington University School of Medicine

Total Trials
29
Recruiting
29
Phases
Phase 2, Phase 1, Phase 1, Phase 2
NCT07223853
Recruiting

AI-driven Clinical Decision Support for Perioperative Blood Orders

Surgery
NCT06926634 Phase 2
Recruiting

Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)

High Grade Neuroendocrine Neoplasms
NCT06799390
Recruiting

Auricular VNS Following Intracerebral Hemorrhage

Intracerebral Hemorrhage
NCT03988283 Phase 1
Recruiting

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

Pediatric Recurrent Central Nervous System Tumors
NCT05831579
Recruiting

Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy

Unresectable Solid Tumor
NCT03424850 Phase 1, Phase 2
Recruiting

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Prostate Cancer
NCT06864754
Recruiting

WashU DIEP Flap Video and Patient Understanding Improvement

Breast Cancer
NCT07397559
Recruiting

Spatiotemporal tSCS in Spinal Cord Injury

Spinal Cord Injuries (SCI)
NCT06503809
Recruiting

Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

Diabetes Mellitus, Type 1
NCT06785129
Recruiting

Endometriosis and Migraine

Migraine
NCT05521984 Phase 1
Recruiting

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Pediatric Brain Tumor
NCT05972343
Recruiting

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Breast Cancer
NCT05685485
Recruiting

Tied Tube Trial in Glaucoma Surgery

Glaucoma Eye
NCT02476786 Phase 2
Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Breast Cancer
NCT06976853 Phase 2
Recruiting

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Crohn Disease (CD)
NCT05826457
Recruiting

North American Prodromal Synucleinopathy Consortium Stage 2

REM Sleep Behavior Disorder
NCT05088798 Phase 2
Recruiting

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Hyperinsulinism
NCT07155200 Phase 1, Phase 2
Recruiting

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Small-cell Lung Cancer
NCT04303702
Recruiting

The Role of Oxytocin in the Second Stage of Labor

Labor Complication
NCT07072481
Recruiting

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

HIV/AIDS
NCT06483100 Phase 2
Recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

Multiple Myeloma
NCT05965245
Recruiting

Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth

Depression
NCT04887935 Phase 1
Recruiting

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Prostate Cancer
NCT02559752
Recruiting

Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy

Central Nervous System
NCT05430490
Recruiting

Cannabis, HIV and Mental Processing Systems

HIV Infections
NCT07219108
Recruiting

Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

Acute Neurological Injury
NCT06340646
Recruiting

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Cholangiocarcinoma
NCT06702033 Phase 2
Recruiting

The Minimalist Trial-2

HPV-Related Oropharynx Squamous Cell Carcinoma
NCT05534243
Recruiting

The ED-AWARENESS-2 Trial

Awareness